GlaxoSmithKline says FDA has halted trials of multiple sclerosis drug

LONDON (AP) - Clinical trials of GlaxoSmithKline PLC's experimental multiple sclerosis drug have been halted by the U.S. Food and Drug Administration, the British pharmaceutical company said Wednesday.

The U.S....More